A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
High-density lipoproteins (HDL) are complex endogenous nanoparticles involved in important functions such as reverse cholesterol transport and immunomodulatory activities, ensuring metabolic homeostasis and vascular health. The ability of HDL to interact with a plethora of immune cells and structura...
Saved in:
Main Authors: | Alankrita Rani (Author), Gunther Marsche (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19
by: Julia T. Stadler, et al.
Published: (2022) -
HDL-Related Parameters and COVID-19 Mortality: The Importance of HDL Function
by: Julia T. Stadler, et al.
Published: (2023) -
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
by: Gunther Marsche, et al.
Published: (2022) -
Role of macrophage in nanomedicine-based disease treatment
by: Siwei Song, et al.
Published: (2021) -
Preeclampsia Affects Lipid Metabolism and HDL Function in Mothers and Their Offspring
by: Julia T. Stadler, et al.
Published: (2023)